title: Silica-associated connective tissue disease. A study of 24 cases.
abstract: We prospectively studied all patients hospitalized for connective tissue disease (CTD) in our French rheumatology clinic from January 1979 to December 1989. Our aims were 1) to determine if CTDs associated with occupational exposure to silica (Si) are currently observed in a rheumatology clinic, and, if so, 2) to describe the major features of Si-associated CTD, and 3) to specify which individuals are affected by Si-associated CTD. Patients were divided into 2 groups based on their responses to a questionnaire: those who had been exposed to Si, and those who had no occupational exposure to Si. Among the 764 patients with CTD studied, 24 (3%) were patients with Si-associated CTD and 740 (97%) were patients with non-Si-associated CTD. The sex ratio between the 2 groups was significantly different with a high frequency of men and of immigrants in the Si-associated CTD group. Two thirds of the patients exposed to Si were male miners or sandblasters, but the other third had more unusual exposures to Si, which may involve members of all socio-economics sectors and both sexes, such as sculpture or exposure to abrasive powders. Progressive systemic sclerosis (PSS) was significantly more prevalent in the Si-associated CTD group. This group also consisted of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), dermatomyositis (DM), and other autoimmune diseases. Si-associated CTD was characterized by the frequency of radiologic lung fibrosis, impaired pulmonary function tests, secondary Sjögren syndrome, and antinuclear antibodies. The number of mineral particles and crystalline Si content were raised in all the bronchoalveolar lavage specimens of Si-exposed patients but in none of those of nonexposed patients. In some cases of Si-associated CTD, the disease was reversible after early cessation of Si exposure. Epidemiologic studies are required to confirm our hypothesis that not only PSS and RA but also SLE and DM are associated with occupational exposure to Si. Pending such results, exposure to Si should be sought in the history of any patient with CTD, especially in a male patient with pulmonary signs, and if present, exposure should be stopped. In the meantime, steps should be taken to ensure that workers exposed to Si in all environments have adequate protection.
authors.affiliation: Department of Rheumatology, Hôpital Pitié-Salpêtrière, Paris, France.
authors.forename: A C
authors.initials: AC
authors.lastname: Koeger
authors.forename: T
authors.initials: T
authors.lastname: Lang
authors.forename: D
authors.initials: D
authors.lastname: Alcaix
authors.forename: B
authors.initials: B
authors.lastname: Milleron
authors.forename: S
authors.initials: S
authors.lastname: Rozenberg
authors.forename: P
authors.initials: P
authors.lastname: Chaibi
authors.forename: J
authors.initials: J
authors.lastname: Arnaud
authors.forename: C
authors.initials: C
authors.lastname: Mayaud
authors.forename: J P
authors.initials: JP
authors.lastname: Camus
authors.forename: P
authors.initials: P
authors.lastname: Bourgeois
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000209:etiology; D003240:Connective Tissue Diseases / Q000175:diagnosis / Q000209:etiology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000517:prevention & control; D016273:Occupational Exposure; D016272:Occupational Health; D011446:Prospective Studies; D011658:Pulmonary Fibrosis / Q000209:etiology; D012822:Silicon Dioxide / Q000009:adverse effects* / Q000097:blood
chemical_list: D012822:Silicon Dioxide